Holen Sie sich die Stockscreener-App
294.53
1.60%
4.63
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$289.90
Offen:
$290.84
24-Stunden-Volumen:
2.97M
Relative Volume:
1.47
Marktkapitalisierung:
$157.01B
Einnahmen:
$32.53B
Nettoeinkommen (Verlust:
$4.23B
KGV:
20.93
EPS:
14.07
Netto-Cashflow:
$6.28B
1W Leistung:
+3.85%
1M Leistung:
-7.86%
6M Leistung:
-4.81%
1J Leistung:
+11.32%
1-Tages-Spanne:
$288.78
$295.48
1-Wochen-Bereich:
$275.56
$295.48
52-Wochen-Spanne:
$260.68
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AMGN | 294.53 | 157.01B | 32.53B | 4.23B | 6.28B | 14.07 |
| LLY | 748.01 | 710.74B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 105.06 | 467.65B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 155.17 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 176.95 | 312.70B | 55.53B | 5.12B | 15.62B | 3.65 |
| MRK | 99.18 | 256.28B | 63.17B | 12.15B | 14.84B | 1.80 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Quest Partners LLC Has $618,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen : Reflecting on Two Patients’ Perseverance and Strength During Lung Cancer Awareness Month - Marketscreener.com
Why Amgen (AMGN) is a Top Value Stock for the Long-Term - Yahoo Finance
Investing in Pharma Stocks? Check These 3 Things First - The Motley Fool
CFS Investment Advisory Services LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Raymond James Trust N.A. Buys 18,921 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zacks Research Has Strong Forecast for Amgen FY2024 Earnings - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by LPL Financial LLC - MarketBeat
Thompson Siegel & Walmsley LLC Has $13.39 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amazon.com Inc., Amgen share losses lead Dow's 275-point drop - MSN
Ontario Teachers Pension Plan Board Has $898,000 Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Celiac Disease Market Key Players AnalysisAmgen, Anokion SA, - openPR
At Amgen Rhode Island, the focus is every action, every person, every time - Providence Business News
Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IPG Mediabrands Wins Amgen U.S. Media Review 10/24/2024 - MediaPost Communications
Amgen and Pfizer appoint new Science executives - European Pharmaceutical Review
Amgen picks prolific biotech founder Chang as new top scientist - BioPharma Dive
Global Blood Cancer Drugs Market to Reach $113.5 Billion by 2031 - openPR
Amgen's MariTide Targets Major Weight Loss With Fewer Doses - Finimize
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $262.99 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Boosted by Intech Investment Management LLC - MarketBeat
Primecap Management Co. CA Has $4.59 Billion Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cornerstone Advisors LLC Buys 2,500 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
King Luther Capital Management Corp Has $166.89 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares - Yahoo Finance
Amgen names new president of research - The Pharma Letter
Amgen Names Howard Chang as Chief Scientific Officer - Marketscreener.com
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Amgen appoints Howard Chang as new chief scientific officer By Investing.com - Investing.com UK
AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT - PR Newswire
UnitedHealth, Amgen share gains lead Dow's 114-point climb - MSN
Advisors Asset Management Inc. Has $35.92 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by First Horizon Advisors Inc. - MarketBeat
Jennison Associates LLC Sells 78,759 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Commerce Bank Buys 5,119 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Strategy Asset Managers LLC Sells 2,761 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Coke Set Aside Only Fraction of Billions They May Owe IRS - Bloomberg Tax
(AMGN) Investment Report - Stock Traders Daily
Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage. - Yahoo! Voices
B. Metzler seel. Sohn & Co. Holding AG Acquires Shares of 52,667 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PNC Financial Services Group Inc. Sells 28,346 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Second Half Financial Partners LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Banque Cantonale Vaudoise Has $6.81 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Prospera Financial Services Inc - MarketBeat
Princeton Capital Management LLC Has $1.97 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Raised by Smead Capital Management Inc. - MarketBeat
Meeder Asset Management Inc. Grows Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
MAI Capital Management Has $12.71 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by AMG National Trust Bank - MarketBeat
Amgen Inc. stock underperforms Monday when compared to competitors - MarketWatch
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.07%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):